Metropolitan Life Insurance Company (MetLife)’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,601
Closed -$49.9K 39
2024
Q1
$49.9K Sell
1,601
-299
-16% -$8.48K ﹤0.01% 1406
2023
Q4
$54.9K Hold
1,900
﹤0.01% 1399
2023
Q3
$51.7K Buy
1,900
+259
+16% +$7.2K ﹤0.01% 1380
2023
Q2
$41.2K Hold
1,641
﹤0.01% 1537
2023
Q1
$37.5K Sell
1,641
-271
-14% -$6.45K ﹤0.01% 1547
2022
Q4
$46.1K Hold
1,912
﹤0.01% 1523
2022
Q3
$42.4K Hold
1,912
﹤0.01% 1572
2022
Q2
$41.1K Buy
1,912
+680
+55% +$15.6K ﹤0.01% 1625
2022
Q1
$27.4K Sell
1,232
-3,659
-75% -$79K ﹤0.01% 1933
2021
Q4
$101K Buy
+4,891
New +$106K ﹤0.01% 2472

Other funds holding ACT

Metropolitan Life Insurance Company (MetLife)'s ACT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Enact Holdings (ACT) in Q2 2024, closing a stake of 1,601 shares — an estimated $49.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACT in Q4 2021 and held it in 10 quarters. The position peaked at $101K in Q4 2021. 185 funds tracked by Wall St. Rank hold ACT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Enact Holdings position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,601 Enact Holdings shares in Q2 2024, an estimated $49.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Enact Holdings in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Enact Holdings position peaked at $101K in Q4 2021.
  • 185 funds tracked by Wall St. Rank held Enact Holdings as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.